Cephaloridine

Cephaloridine

SCHEMBL3936

O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 12/20 1.00
MAPT P10636 8/20 1.00
LMNA P02545 5/20 1.00
KDM4E B2RXH2 5/20 1.00
HPGD P15428 4/20 1.00
KMT2A Q03164 3/20 1.00
NR1I2 O75469 3/20 1.00
MEN1 O00255 2/20 1.00
SLC22A6 Q4U2R8 2/20 1.00
SLC22A8 Q8TCC7 2/20 1.00
SLC22A11 Q9NSA0 2/20 1.00
ALDH1A1 P00352 2/20 1.00
RECQL P46063 2/20 1.00
ALOX15 P16050 1/20 1.00
PTGS1 P23219 1/20 1.00
HSD17B10 Q99714 5/20 0.83
CYP3A4 P08684 3/20 0.69
APEX1 P27695 3/20 0.69
POLB P06746 3/20 0.69
GLA P06280 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cephaloridine SCHEMBL2908926 1.00 TDP1 (1.00) TDP1MAPTLMNAKDM4EHPGD
Cephaloridine SCHEMBL10665298 1.00 TDP1 (1.00) TDP1MAPTLMNAKDM4EHPGD
Cephaloridine SCHEMBL10665308 1.00 TDP1 (1.00) TDP1MAPTLMNAKDM4EHPGD
Cephaloridine SCHEMBL10773515 0.99 TDP1 (0.98) TDP1MAPTLMNAKDM4EHPGD
Cephaloridine SCHEMBL19100513 0.99 TDP1 (0.98) TDP1MAPTLMNAKDM4EHPGD
Cephaloridine SCHEMBL7845737 0.99 TDP1 (0.98) TDP1MAPTLMNAKDM4EHPGD
Cephaloridine SCHEMBL6526642 0.99 TDP1 (0.98) TDP1MAPTLMNAKDM4EHPGD
Cephaloridine SCHEMBL6650322 0.94 TDP1 (0.88) TDP1MAPTLMNAKDM4EHPGD
Cefalonium SCHEMBL28295839 0.94 TDP1 (0.95) TDP1MAPTLMNAKDM4EHPGD
SCHEMBL11142081 0.93 TDP1 (0.87) TDP1MAPTLMNAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 50938 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637481-B2 Boronic acid derivatives and therapeutic uses thereof QPEX BIOPHARMA, INC. (US) 2026-05-26 US claimed
US-20260108619-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2026-04-23 US claimed
US-12576124-B2 Formulation of a conjugate of a tubulysin analog to a cell-binding molecule HANGZHOU DAC BIOTECH CO., LTD (CN) 2026-03-17 US claimed
EP-4659014-A1 EMULSION-BASED THICK-FILM ANTIFOULING COATING FOR HIGHLY SENSITIVE ELECTROCHEMICAL SENSING President And Fellows Of Harvard College (US) 2025-12-10 EP claimed
US-20250339551-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) 2025-11-06 US claimed
EP-4642492-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
EP-4642484-A1 TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP claimed
US-20250295668-A1 METHODS FOR INDUCING COLANIC ACID BIOSYNTHESIS HOWARD HUGHES MEDICAL INSTITUTE (US) 2025-09-25 US claimed
US-12371429-B2 Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof RECREO PHARMACEUTICALS LLC (US) 2025-07-29 US claimed
US-20250222118-A1 Beta-Lactam-Cannabinoid Conjugate Molecules DIVERSE BIOTECH INC (US) 2025-07-10 US claimed
WO-1980000910-A1 ASSEMBLY OF ELEMENTS FOR THE CONSTRUCTION OF CUPBOARD WALLS OR SIMILAR HERRIG W (DE) 1980-05-15 WO claimed
EP-0009019-A1 PROCESS AND DEVICE FOR PRODUCING A PACKING, AND THE PACKING PRODUCED. PARISIENNE IMPRESSION (FR) 1980-03-19 EP claimed
EP-0007717-A1 Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1980-02-06 EP claimed
EP-0007027-A1 Polymerisation of conjugated dienes in solution BAYER AG (DE) 1980-01-23 EP claimed
WO-1979000409-A1 PROCESS AND DEVICE FOR PRODUCING A PACKING,AND THE PACKING PRODUCED PARISIENNE IMPRESSION CARTONNA (FR) 1979-07-12 WO claimed
WO-1979000268-A1 A METHOD AND A DEVICE FOR REMOVING CORKS FROM VESSELS KEMI INTRESSEN AB (SE) 1979-05-17 WO claimed
EP-0001956-A1 Guiding and actuating device for a sliding door FAIVELEY S.A. (FR) 1979-05-16 EP claimed
US-4028355-A Cephalosporin purification process SMITHKLINE CORPORATION (US) 1977-06-07 US claimed
US-3987797-A ANTIMICROBIAL SUTURES ETHICON, INC. (US) 1976-10-26 US claimed
US-3937655-A Method for preparing stable β-lactam-type-antibiotic susceptibility test discs ELI LILLY AND COMPANY (US) 1976-02-10 US claimed